Published in Annu Rev Immunol on January 01, 1997
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science (2002) 19.77
Antiviral actions of interferons. Clin Microbiol Rev (2001) 13.06
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet (2008) 8.37
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A (1998) 6.82
Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood (2008) 6.81
Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A (2002) 5.28
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med (2010) 4.90
Immunity to murine chlamydial genital infection. Infect Immun (2002) 4.64
Mapping of transcription factor binding regions in mammalian cells by ChIP: comparison of array- and sequencing-based technologies. Genome Res (2007) 4.59
TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol (2008) 4.21
Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med (2001) 3.75
Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection. J Exp Med (2001) 3.64
Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61
Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A (2000) 3.47
Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc Natl Acad Sci U S A (2002) 3.28
Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest (2003) 3.04
Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med (2000) 3.04
Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation. J Exp Med (1998) 2.89
Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis (2007) 2.89
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80
Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med (1999) 2.76
Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J (1999) 2.70
Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med (2000) 2.65
Memory CD4+ T cells induce innate responses independently of pathogen. Nat Med (2010) 2.61
CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma. Proc Natl Acad Sci U S A (1999) 2.60
Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci U S A (2001) 2.56
Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci U S A (2001) 2.44
The molecular profile of microglia under the influence of glioma. Neuro Oncol (2012) 2.38
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med (2001) 2.37
T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc Natl Acad Sci U S A (2003) 2.34
ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol (2005) 2.31
Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med (2000) 2.25
Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis (2005) 2.24
The two faces of interferon-γ in cancer. Clin Cancer Res (2011) 2.20
Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res (2010) 2.15
Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest (1999) 2.09
Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest (2005) 2.06
Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol (2009) 2.05
Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev (2005) 2.01
MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol (2011) 2.00
Stat1-independent regulation of gene expression in response to IFN-gamma. Proc Natl Acad Sci U S A (2001) 1.96
Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. AIDS (2010) 1.94
Using personal glucose meters and functional DNA sensors to quantify a variety of analytical targets. Nat Chem (2011) 1.93
Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest (1998) 1.93
Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol (2001) 1.92
Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J Exp Med (2002) 1.88
The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci U S A (2004) 1.85
An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A (2001) 1.85
Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med (2002) 1.85
Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J Immunol (2009) 1.81
MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc Natl Acad Sci U S A (2002) 1.79
Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood (2006) 1.79
IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol (2010) 1.77
Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology (2004) 1.77
Malnutrition and gastrointestinal and respiratory infections in children: a public health problem. Int J Environ Res Public Health (2011) 1.76
Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol (2004) 1.74
Maximal induction of a subset of interferon target genes requires the chromatin-remodeling activity of the BAF complex. Mol Cell Biol (2002) 1.73
Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol (2010) 1.73
Lipoproteins of bacterial pathogens. Infect Immun (2010) 1.73
Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS One (2010) 1.73
Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS One (2010) 1.73
The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. Infect Immun (2003) 1.72
Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J Virol (2005) 1.71
Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest (2003) 1.69
Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect Immun (1998) 1.69
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med (2005) 1.68
Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells. J Virol (1999) 1.68
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest (2015) 1.67
Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. J Clin Invest (1998) 1.67
Proteasomes in immune cells: more than peptide producers? Nat Rev Immunol (2009) 1.67
Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infect Immun (2001) 1.66
Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun (1998) 1.64
Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect Immun (2006) 1.63
The proteasome activator 11 S REG (PA28) and class I antigen presentation. Biochem J (2000) 1.62
Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol (2010) 1.61
Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One (2007) 1.61
A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J Exp Med (2004) 1.59
Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. Proc Natl Acad Sci U S A (2000) 1.57
CD4⁺T cells: differentiation and functions. Clin Dev Immunol (2012) 1.56
Immunotherapeutic approaches for glioma. Crit Rev Immunol (2009) 1.55
IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci. J Neuroinflammation (2012) 1.54
Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm (2013) 1.54
Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc Natl Acad Sci U S A (1997) 1.52
Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol (2001) 1.52
Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J Virol (2002) 1.51
Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J Virol (2000) 1.50
β-Adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruption. Brain Behav Immun (2012) 1.50
Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways. J Exp Med (2007) 1.47
Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect Immun (1998) 1.47
MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma. Proc Natl Acad Sci U S A (2002) 1.47
Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms. J Virol (2005) 1.45
CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog (2006) 1.45
Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus. PLoS One (2012) 1.45
Pathogenesis of intracranial aneurysm is mediated by proinflammatory cytokine TNFA and IFNG and through stochastic regulation of IL10 and TGFB1 by comorbid factors. J Neuroinflammation (2015) 1.44
IFNγ signaling endows DCs with the capacity to control type I inflammation during parasitic infection through promoting T-bet+ regulatory T cells. PLoS Pathog (2015) 1.43
Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med (2011) 1.43
Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature (1977) 16.54
Identification of marrow-derived and thymus-derived small lymphocytes in the lymphoid tissue and thoracic duct lymph of normal rats. J Exp Med (1972) 3.54
The life-span and recirculation of marrow-derived small lymphocytes from the rat thoracic duct. J Exp Med (1972) 3.42
MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature (1991) 2.94
Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature (1992) 2.61
Two families of GTPases dominate the complex cellular response to IFN-gamma. J Immunol (1998) 2.27
Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature (1992) 2.01
Specific positive selection of lymphocytes reactive to strong histocompatibility antigens. J Exp Med (1974) 1.98
Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature (1994) 1.88
Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature (1992) 1.76
The origin of antibody forming cells from lymphocytes. Antibiot Chemother (1969) 1.75
Monoclonal antibodies as tools to analyze the serological and genetic complexities of major transplantation antigens. Immunol Rev (1979) 1.67
Interaction of DNA with a porphyrin ligand: evidence for intercalation. Nucleic Acids Res (1979) 1.56
The identification of sera distinguishing marrow-derived and thymus-derived lymphocytes in the rat thoracic duct. Immunology (1974) 1.49
Meticillin-resistant Staphylococcus aureus in the community: homeless are also at risk. J Hosp Infect (2008) 1.46
Inhibition of experimental allergic encephalomyelitis in rats severely depleted of T cells. Science (1974) 1.40
SPECIFIC positive and negative selection of rat lymphocytes reactive to strong histocompatibility antigens: activation with alloantigens in vitro and in vivo. J Immunol (1976) 1.38
Speeding up necropsy histology reports in a teaching hospital. J Clin Pathol (1993) 1.37
The gene conversion hypothesis of MHC evolution: a review. Immunogenetics (1999) 1.30
The role of recirculating lymphocytes in the immunological competence of rat bone marrow cells. Cell Immunol (1972) 1.28
Some biological aspects of lymphocytes reactive to strong histocompatibility alloantigens. Transplant Rev (1972) 1.24
Retracted Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease. J Immunol (1996) 1.24
A trans-acting major histocompatibility complex-linked gene whose alleles determine gain and loss changes in the antigenic structure of a classical class I molecule. J Exp Med (1989) 1.22
Induction of DNA damage by porphyrin photosensitizers. Cancer Res (1981) 1.20
A recombinant in the major histocompatibility complex of the rat. Nature (1977) 1.19
Genetic control of transplant rejection. Transplantation (1982) 1.18
Collaboration between thymus-derived and marrow-derived thoracic duct lymphocytes in the hemolysin response of the rat. Cell Immunol (1972) 1.17
Immunology. Disease and evolution. Nature (1991) 1.13
Investigation of the conformations of four tetrapeptides by nuclear magnetic resonance and circular dichroism spectroscopy, and conformational energy calculations. Macromolecules (1976) 1.08
Expression of the protein kinase C substrate pleckstrin in macrophages: association with phagosomal membranes. J Immunol (1999) 1.07
Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia. Clin Microbiol Infect (2009) 1.05
The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. Immunity (1996) 1.04
Concerted evolution of class I genes in the major histocompatibility complex of murine rodents. Proc Natl Acad Sci U S A (1990) 1.02
Monoclonal anti-rat MHC (H-1) alloantibodies. Curr Top Microbiol Immunol (1978) 1.01
Intercalative and nonintercalative binding of large cationic porphyrin ligands to polynucleotides. Nucleic Acids Res (1983) 1.01
Identification and characterization of a mammalian protein interacting with 20S proteasome precursors. Proc Natl Acad Sci U S A (2000) 0.99
Characterization of tryptophan transport in human placental brush-border membrane vesicles. Biochem J (1986) 0.99
Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules. Curr Biol (1999) 0.98
The mechanism of graft rejection and the concept of antigenic strength. Scand J Immunol (1981) 0.98
The alloantigenic organization of RT1Aa, a class I major histocompatibility complex molecule of the rat. Eur J Immunol (1984) 0.97
Co-evolution of rat TAP transporters and MHC class I RT1-A molecules. Curr Biol (1998) 0.96
Studies in the rat of antibody-coated and N-ethylmaleimide-treated erythrocyte clearance by the spleen. I. Effects of in vivo complement activation. Immunology (1986) 0.94
Immune response genes controlling responsiveness to major transplantation antigens. Specific major histocompatibility complex-linked defect for antibody responses to class I alloantigens. J Exp Med (1982) 0.94
Distinct functional properties of the TAP subunits coordinate the nucleotide-dependent transport cycle. Curr Biol (2001) 0.93
Histological demonstration of mosaicism in a series of chimeric rats produced between congenic strains. Science (1985) 0.93
Functional analysis by site-directed mutagenesis of the complex polymorphism in rat transporter associated with antigen processing. J Immunol (1998) 0.91
The major histocompatibility complex of the rat: a partial review. Metabolism (1983) 0.91
Effectiveness of antihistamines in the symptomatic management of the common cold. JAMA (1979) 0.90
On the relationship between initiator and effector cells in the response to major tansplantation antigens. Transplant Proc (1973) 0.90
The class II genes of the rat MHC. J Immunol (1989) 0.89
The major histocompatibility complex class II-linked cim locus controls the kinetics of intracellular transport of a classical class I molecule. J Exp Med (1991) 0.89
Studies in the rat of antibody-sensitized and N-ethylmaleimide-treated erythrocyte clearance by the liver: effects of immune complex infusion and complement activation. Immunology (1988) 0.89
Isolation of a functional cDNA encoding the RT1.Au MHC class I heavy chain by a novel PCR-based method. Immunogenetics (1995) 0.89
Practolol and isoprenaline in status asthmaticus. Lancet (1972) 0.89
Cim: an MHC class II-linked allelism affecting the antigenicity of a classical class I molecule for T lymphocytes. Immunogenetics (1991) 0.88
On the possibility of multiple t-cell receptors. Cold Spring Harb Symp Quant Biol (1977) 0.87
The mechanism of synergistic complement-mediated lysis of rat red cells by monoclonal IgG antibodies. Eur J Immunol (1983) 0.87
Studies in cobra venom factor treated rats of antibody coated erythrocyte clearance by the spleen: differential influence of red blood cell antigen number on the inhibitory effects of immune complexes on Fc dependent clearance. Clin Exp Immunol (1986) 0.87
Demonstration of MHC-specific haemolytic plaque-forming cells. Nature (1979) 0.87
Cloning and expression of class I major histocompatibility complex genes of the rat. J Exp Med (1992) 0.86
Isolation of six monoclonal alloantibodies against rat histocompatibility antigens: clonal competition. Immunology (1980) 0.85
Interaction of proline, 5-oxoproline, and pipecolic acid for renal transport in the rabbit. J Biol Chem (1983) 0.85
Antigen processing. Peptides and the proteasome. Nature (1993) 0.85
Analysis of lymphocytes reactive to histocompatibility antigens. I. A quantitative titration assay for mixed lymphocyte interactions in the rat. Cell Immunol (1979) 0.85
Expression and characterization of ovine major histocompatibility complex class II (OLA-DR) genes. Anim Genet (1992) 0.84
Studies in the rat of antibody-coated and N-ethylmaleimide-treated erythrocyte clearance by the spleen. II. Effects of immune complex infusion. Immunology (1986) 0.84
Class II major histocompatibility complex genes of the sheep. Anim Genet (1991) 0.84
Heterogeneity of the tolerant state in rats with long established skin grafts. J Immunol (1980) 0.84
Primary in vitro antibody formation in the rat: partial characterization and properties of an inhibitor cell present in normal spleen. Eur J Immunol (1978) 0.83
Localized conformational changes induced in a class I major histocompatibility antigen by the binding of monoclonal antibodies. J Immunol (1984) 0.83
Audit of serum theophylline concentrations in patients from general practice. J R Coll Gen Pract (1987) 0.82
Evidence from a UK teaching hospital that MRSA is primarily transmitted by the hands of healthcare workers. J Hosp Infect (2010) 0.82
Rat RT1 orthologs of mouse H2-M class Ib genes. Immunogenetics (1995) 0.81
The role of lymphocytes in antibody formation. 3. The origin from small lymphocytes of cells forming direct and indirect haemolytic plaques to sheep erythrocytes in the rat. Proc R Soc Lond B Biol Sci (1972) 0.81
Antibody density on rat red cells determines the rate of activation of the complement component C1. Eur J Immunol (1985) 0.81
The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts. J Exp Med (1979) 0.81
Endocrine disrupting compounds: effect of octylphenol on reproduction over three generations. Theriogenology (2001) 0.81
Molecular evolution. How old is a polymorphism? Nature (1988) 0.81
Demonstration of hepatic Fc receptor function in vivo. Clin Exp Immunol (1989) 0.80
Mosaic pattern and lineage analysis in chimeras. Cell Differ Dev (1988) 0.80
Analysis of lymphocytes reactive to histocompatibility antigens. III. Detection of inclusion among allo-reactive lymphocyte populations by specific depletion of reactive cells. Cell Immunol (1979) 0.80
MHC class I molecules compete in the endoplasmic reticulum for access to transporter associated with antigen processing. J Immunol (1998) 0.80
Antimicrobial effects of murine mesenchymal stromal cells directed against Toxoplasma gondii and Neospora caninum: role of immunity-related GTPases (IRGs) and guanylate-binding proteins (GBPs). Med Microbiol Immunol (2012) 0.79
Differential effect of transporter Tap 2 gene introduction into RMA-S cells on viral antigen processing. Eur J Immunol (1993) 0.79
The distribution of Tap2 alleles among laboratory rat RT1 haplotypes. Immunogenetics (1994) 0.78
Variation in the biosynthesis of the rat RT1.Aa classical class I antigen due to the cim system. Transplant Proc (1990) 0.78
The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands. J Med Econ (2011) 0.77
Analysis of lymphocytes reactive to histocompatibility antigens. II. Exponential alloantigen-dependent lymphocyte growth in vitro. Cell Immunol (1979) 0.77
Protein dissociation from DNA in model systems and chromatin. Nucleic Acids Res (1978) 0.77
Xenogeneic responses in vitro in the Syrian hamster, Mesocricetus auratus. I. Evidence for a normal T cell repertoire. Int Immunol (1991) 0.77
Membrane recycling and antigen presentation. Bioessays (1986) 0.77
Immunological help at last. Nature (1985) 0.77
Simultaneous determination of eight lipid peroxidation degradation products in urine of rats treated with carbon tetrachloride using gas chromatography with electron-capture detection. J Chromatogr B Biomed Sci Appl (1997) 0.77
An analysis of the antigen binding site of RT1.Aa suggests an allele-specific motif. Immunogenetics (1995) 0.76
Cloning, expression, and evolution of rat classical and nonclassical class I genes. Transplant Proc (1990) 0.76
Antigen recognition. Curr Opin Immunol (1997) 0.76
The phenotypic and molecular characterization of Nb2 lymphoma cells activated with IL-2 and human growth hormone. Immunology (1989) 0.75
Chimeric drift in blood cell populations of chimeric rats constructed between congenic strains. Pathobiology (1993) 0.75